MedTrace Logo

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

NCT00160212 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2009-01-30

No results posted yet for this study

Summary

This study is to compare the efficacy and safety of increasing doses of SLV306 with amlodipine.

Conditions

Interventions

DRUG

Daglutril

Sponsors & Collaborators

  • Solvay Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Global Clinical Director Solvay · Solvay Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31

Countries

  • Australia
  • Bulgaria
  • Denmark
  • Estonia
  • Germany
  • Hungary
  • Israel
  • Latvia
  • Lithuania
  • Slovakia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00160212 on ClinicalTrials.gov